ABK Biomedical
About:
ABK Biomedical combines the clinical market with biomaterials with a focus on treating hypervascular tumors.
Website: http://www.abkbiomedical.com/
Top Investors: F-Prime Capital, Innovacorp, Eight Roads Ventures, Sante Ventures, Varian
Description:
ABK Biomedical combines the clinical market with biomaterials. It specializes in improving treatment options for patients with hypervascular tumors. The company is dedicated to transforming an interventional radiology procedure called embolization.
Total Funding Amount:
$67.4M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Halifax, Nova Scotia, Canada
Founded Date:
2012-01-01
Contact Email:
info(AT)abkbiomedical.com
Founders:
Bob Abraham, Daniel Boyd, Sharon Kehoe
Number of Employees:
11-50
Last Funding Date:
2022-12-06
IPO Status:
Private
Industries:
© 2025 bioDAO.ai